← Back to guidelines
Cardiology4 papers

Biventricular congestive heart failure

Last edited: 4/10/2026

Overview

Biventricular pacing (BiVP) is a therapy for heart failure with reduced ejection fraction (HFrEF) and left bundle-branch block (LBBB) aimed at improving cardiac resynchronization 14. Conduction system pacing (CSP) is being investigated as a potentially more physiologic alternative to BiVP 14.

Diagnosis

  • Natriuretic peptides (BNP and NT-proBNP) are globally used for heart failure diagnosis and can aid in risk stratification 2.
  • Heart failure with reduced ejection fraction (HFrEF) is characterized by symptomatic presentation (NYHA classes II-III) and left ventricular ejection fraction (LVEF) of 35% or less 1.
  • Left bundle-branch block (LBBB) is defined by a QRS duration of ≥130 milliseconds 1.
  • Multivariable prediction models can estimate the risk of incident heart failure in the general population 3.
  • Management

  • Conduction system pacing (CSP), preferentially left bundle-branch area pacing, is being compared to biventricular pacing (BiVP) for HF-related outcomes 1.
  • Angiotensin receptor neprilysin inhibitors (ARNIs) are a therapeutic option in heart failure management 2.
  • Natriuretic peptides themselves have been used therapeutically (nesiritide, carperitide) 2.
  • Key Recommendations

  • Conduction system pacing (CSP) is being investigated as a potentially physiologic alternative to conventional biventricular pacing (BiVP) for cardiac resynchronization therapy in patients with heart failure and conduction system disease 4.
  • CSP is being compared to BiVP in patients with symptomatic HFrEF (NYHA classes II-III), LVEF ≤35%, and LBBB (QRS duration ≥130 ms) 1.
  • Natriuretic peptides (BNP and NT-proBNP) are important for the diagnosis and risk stratification of heart failure 2.
  • References

    1 Zimerman A, Dal Forno A, Rohde LE, Ternes CM, Alves FD, Damiani LP et al.. Conduction System vs Biventricular Pacing in Heart Failure: The PhysioSync-HF Randomized Clinical Trial. JAMA cardiology 2026. link 2 Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J et al.. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Journal of cardiac failure 2023. link 3 Nadarajah R, Younsi T, Romer E, Raveendra K, Nakao YM, Nakao K et al.. Prediction models for heart failure in the community: A systematic review and meta-analysis. European journal of heart failure 2023. link 4 Herweg B, Welter-Frost A, Wilson Ii DR, Vijayaraman P. Conduction System Pacing for Cardiac Resynchronization Therapy. Cardiac electrophysiology clinics 2022. link

    Original source

    1. [1]
      Conduction System vs Biventricular Pacing in Heart Failure: The PhysioSync-HF Randomized Clinical Trial.Zimerman A, Dal Forno A, Rohde LE, Ternes CM, Alves FD, Damiani LP et al. JAMA cardiology (2026)
    2. [2]
    3. [3]
      Prediction models for heart failure in the community: A systematic review and meta-analysis.Nadarajah R, Younsi T, Romer E, Raveendra K, Nakao YM, Nakao K et al. European journal of heart failure (2023)
    4. [4]
      Conduction System Pacing for Cardiac Resynchronization Therapy.Herweg B, Welter-Frost A, Wilson Ii DR, Vijayaraman P Cardiac electrophysiology clinics (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG